Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands	9 Months Ended
	Oct. 01, 2011	Oct. 02, 2010
OPERATING ACTIVITIES
Net earnings	$ 700,794	$ 700,992
Adjustments to reconcile net earnings to net cash from operating activities:
Depreciation and amortization	224,633	175,813
Amortization of debt (premium)/discount	(4,051)	692
Inventory step-up amortization	29,442
Stock-based compensation	58,682	53,142
Excess tax benefits from stock-based compensation	(8,686)	(10,963)
Gain on sale of investment		(4,929)
Purchased in-process research and development charges	4,400	12,244
Deferred income taxes	(24,180)	(7,442)
Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable	(52,827)	(89,313)
Inventories	(18,642)	(10,652)
Other current assets	57,953	(51,678)
Accounts payable and accrued expenses	(68,046)	22,678
Income taxes payable	22,143	977
Other, net	19,538
Net cash provided by operating activities	941,153	791,561
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(236,005)	(226,299)
Business acquisition payments, net of cash acquired		(128,903)
Other, net	(32,364)	(113,573)
Net cash used in investing activities	(268,369)	(468,775)
FINANCING ACTIVITIES
Proceeds from exercise of stock options and stock issued	285,807	107,343
Excess tax benefits from stock-based compensation	8,686	10,963
Common stock repurchased, including related costs	(809,204)
Dividends paid	(137,783)
Issuances/(payments) of commercial paper borrowings, net	444,600
Borrowings under debt facilities	78,417	671,094
Payments under debt facilities	(78,417)	(655,723)
Net cash provided by (used in) financing activities	(207,894)	133,677
Effect of currency exchange rate changes on cash and cash equivalents	(5,700)	2,224
Net increase in cash and cash equivalents	459,190	458,687
Cash and cash equivalents at beginning of period	500,336	392,927
Cash and cash equivalents at end of period	$ 959,526	$ 851,614